The latest headlines across every section, pulled from official and open-access sources.
EMA is actively monitoring the ongoing hantavirus outbreak linked to a cruise ship, in coordination with other EU bodies.The virus has been identified as Andes hantavirus, the…
EMA's office is closed from 18:00 on 13 May 2026 until 08:30 on 18 May 2026.The product emergency hotline is available outside working hours and on public holidays. To reach…
EMA welcomes the provisional agreement reached by the European Parliament and the Council of the European Union on the proposed Critical Medicines Act (CMA), which represents an…, “At a time of increasing global disruptions, resilient and secure supply chains for critical medicines are essential to protect public health across the EU. Today’s…, In recent years, EU Member States have faced serious medicine shortages and global challenges such as the COVID-19 pandemic and geopolitical tensions have exposed…
R. Zhuo et al.
Shoppers are being urged to look out for lumps, swelling, skin changes and unexplained bruising as Morrisons teams up with the NHS to put cancer advice on its own-brand bath and shower products. The range of nine new shower and bath products will carry messages including “Be body aware” and “Know the signs of cancer”, […]
PHILADELPHIA, May 11, 2026—Telemedicine can improve health equity by helping patients overcome barriers to in-person care, but meaningful policy changes are essential for lasting benefits, says the American College of Physicians (ACP). In a new paper, “ Telemedicine Policy and Practice: A Position Paper from the American College of Physicians ” published today in Annals of Internal Medicine , ACP issues recommendations for policymakers, regulators and health systems about how to improve telemedicine. ACP’s recommendations aim to ensure telemedicine is equitable, grounded in evidence, and used…
Amyotrophic lateral sclerosis (ALS), which affects about 25 000 individuals in the US, causes progressive weakness but has varied presentations. Several FDA-approved medications are now available for ALS. Author John Ravits, MD, of UC San Diego School of Medicine joins JAMA Deputy Editor Mary M. McDermott, MD, to discuss current evidence regarding diagnosis and treatment of ALS. Related Content: Amyotrophic Lateral Sclerosis Pridopidine in Amyotrophic Lateral Sclerosis What Is Amyotrophic Lateral Sclerosis? CNM-Au8 in Amyotrophic Lateral Sclerosis Safety and Efficacy of PrimeC in Amyotrophic…
by Silja Kosola Social media has evolved from connection to compulsion, disproportionately harming children and adolescents. Addictive designs together with developmental vulnerability fuel mental health risks and highlight the urgent need for stricter age limits and stronger protections. In this Perspective, Silja Kosola outlines how social media disproportionately harms child and adolescent mental health, and argues that while recent policy changes aimed at protecting youth from social media are welcome, stricter age limits and greater accountability of social media companies are needed.
FDA announced it is soliciting input on efforts with respect to drug repurposing to help address unmet medical needs across a range of diseases and conditions.
To the people of Tenerife, My name is Tedros, and I serve as the Director-General of the World Health Organization, the United Nations agency responsible for global public health. It is not common for me to write directly to the people of a single community, but today I feel it is not only appropriate, it is necessary. I want to speak to you directly, not through press releases or technical briefings, but as one human being to another, because you deserve that. I know you are worried. I know that when you hear the word “outbreak” and watch a ship sail toward your shores, memories…
FDA issued an approval for Bizengri (zenocutuzumab-zbco), a drug that treats NRG1 fusion-positive cholangiocarcinoma, an ultra-rare, aggressive cancer that forms in the bile ducts.
by Xiong-yu Liao, Hong Zheng, Jian-pei Fang, Dun-hua Zhou, Kun-yin Qiu Background Minimal residual disease (MRD) monitoring is a cornerstone of risk stratification in pediatric acute myeloid leukemia (AML), with a threshold of 0.1% conventionally defining positivity by flow cytometry. Advances in flow cytometric technologies, enabling detection of leukemic cells with higher sensitivity and specificity, warrant a reevaluation of whether a lower threshold improves prognostic accuracy. Methods and findings We conducted a retrospective cohort study using data from the Therapeutically Applicable…
by Gokul Parameswaran, Sadeer Al-Kindi, Sanjay Rajagopalan Climate change accelerates non-communicable diseases (NCDs) through cascading environmental disruptions and is attributed to driving increased NCD-related mortality. Yet this syndemic remains invisible and underfunded. We detail why addressing the climate-NCD intersection is critical for improving health. In this Perspective, Sanjay Rajagopalan and colleagues discusses how climate change accelerates non-communicable diseases (NCDs) and exacerbates NCD-related mortality, and calls for greater visibility and funding to address this…
The U.S. Food and Drug Administration today issued a final guidance for industry, Postapproval Pregnancy Safety Studies, with recommendations on different methodologies that can be used in the postapproval setting to study the safety of drugs and biological products when used during pregnancy.
The U.S. government is actively monitoring and responding to a hantavirus outbreak linked to the M/V Hondius cruise ship. At this time, the risk to the American public remains extremely low.
A CDC investigation notice regarding a multistate outbreak of Salmonella infections has been posted
The U.S. healthcare sector accounts for roughly 8.5% of total greenhouse gas (GHG) emissions, driven largely by energy use, supply chains, transportation and waste. While much of the conversation about healthcare decarbonization has focused on hospitals and clinical care, health plans play a powerful—and often overlooked—role in shaping how care is delivered and how resources […] The post New NCQA Research: What Health Plan Leaders Can Do to Reduce Climate Impact appeared first on NCQA .
Dr Tedros Adhanom Ghebreyesus, WHO Director-General, briefed media today on a cluster of hantavirus cases linked to a cruise ship, the MV Hondius. Eight cases have been reported so far, including three deaths. Five of the 8 cases have been confirmed as hantavirus. The hantavirus involved is the Andes virus, the only species known to be capable of limited transmission between humans, linked to close and prolonged contact. Describing the situation, Dr Tedros said, “While this is a serious incident, WHO assesses the public health risk as low.” He noted that given the incubation…
This report describes a fatal human case of highly pathogenic avian influenza in Washington.
This report describes 139 human exposures to cats infected with A(H5N1) in Los Angeles, California.
There is an outbreak of ciguatera fish poisoning in Vanuatu.
The Administration is closely monitoring the situation with U.S. travelers.
FDA announced major steps in its bold initiative to modernize the agency. The agency launched Elsa 4.0, a significant upgrade to the agency’s internal AI tool available to all FDA staff, from scientific reviewers to investigators.
This week, we present research on high-risk coronary intervention strategies, targeted therapy for pancreatic cancer, an mRNA influenza vaccine, and treatments for severe scabies and sickle cell disease. We review cerebral amyloid angiopathy and follow a complex case of a disseminated infection. Perspectives address the impact of corporate medicine on medical training and drug pricing policy.